We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
(-8.1%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-13.95%
Top 10 Holdings %
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$10.9M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.33M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 4 |
NetEase
NTES
|
+$7.01M |
| 5 |
Micron Technology
MU
|
+$6.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$65.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$62.2M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.1M |
| 5 |
Alibaba
BABA
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Consumer Discretionary | 11.71% |
| 3 | Healthcare | 9.05% |
| 4 | Industrials | 8.79% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
NerdWallet
NRDS
$652M
| $104K | 0.01% |
+11,033
| New | +$125K |
|
927
Caribou Biosciences
CRBU
$164M
| $102K | 0.01% |
+23,900
| New | +$107K |
|
928
TETRA Technologies
TTI
$1.26B
| $101K | 0.01% |
29,818
-54,124
| -64% | -$157K |
|
929
Viant Technology
DSP
$265M
| $100K | 0.01% |
+21,786
| New | +$96.4K |
|
|
SBDS
930
DELISTED
Solo Brands Inc
SBDS
| $99K | 0.01% |
+438
| New | +$109K |
|
931
Lifestance Health
LFST
$4.14B
| $98.4K | 0.01% |
+10,773
| New | +$89.5K |
|
932
Perimeter Solutions
PRM
$5.77B
| $97.4K | 0.01% |
15,833
+5,408
| +52% | +$36.2K |
|
|
OKUR
933
OnKure Therapeutics
OKUR
$168M
| $97.1K | 0.01% |
1,480
| – | – |
|
934
Daktronics
DAKT
$1.04B
| $95.1K | 0.01% |
+14,858
| New | +$87.2K |
|
935
C4 Therapeutics
CCCC
$412M
| $93.5K | 0.01% |
+34,000
| New | +$109K |
|
936
Atea Pharmaceuticals
AVIR
$420M
| $90.1K | 0.01% |
24,078
-4,422
| -16% | -$16.6K |
|
937
Algoma Steel
ASTL
$431M
| $88.9K | 0.01% |
12,518
-24,074
| -66% | -$179K |
|
|
KZR
938
DELISTED
Kezar Life Sciences
KZR
| $88.7K | 0.01% |
3,620
+1,987
| +122% | +$51.7K |
|
|
KNTE
939
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $87.1K | 0.01% |
+28,754
| New | +$111K |
|
|
LONA
940
LeonaBio Inc
LONA
$72.1M
| $84.7K | 0.01% |
2,872
-1,424
| -33% | -$40.6K |
|
941
The Honest Company
HNST
$586M
| $84K | 0.01% |
50,000
| – | – |
|
|
IVAC
942
DELISTED
Intevac Inc
IVAC
| $83.4K | 0.01% |
+22,237
| New | +$119K |
|
|
LL
943
DELISTED
LL Flooring Holdings, Inc.
LL
| $81.2K | 0.01% |
+21,200
| New | +$81.9K |
|
944
Porch Group
PRCH
$1.8B
| $80.3K | 0.01% |
+58,173
| New | +$70.5K |
|
|
VISN
945
Vistance Networks Inc
VISN
$2.52B
| $80.2K | 0.01% |
+14,243
| New | +$68.1K |
|
|
OSG
946
DELISTED
Overseas Shipholding Group Inc.
OSG
| $78.7K | 0.01% |
+18,865
| New | +$72.9K |
|
947
ReNew
RNW
$2.25B
| $77.1K | 0.01% |
14,068
-517
| -4% | -$2.83K |
|
|
THRD
948
DELISTED
Third Harmonic Bio
THRD
| $76.2K | 0.01% |
+15,842
| New | +$75.4K |
|
949
Rayonier Advanced Materials
RYAM
$610M
| $75.8K | ﹤0.01% |
+17,700
| New | +$83.7K |
|
|
WHWK
950
Whitehawk Therapeutics
WHWK
$271M
| $75.7K | ﹤0.01% |
+11,074
| New | +$86.1K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.
- Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
- Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
- Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
- Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
- Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
- Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.